Citation: Bl. Sauer et Ma. Kodakimble, A CHANGING HEALTH-CARE ENVIRONMENT - ITS IMPACT ON UCSF GRADUATES PRACTICE PATTERNS AND PERCEPTIONS, American journal of pharmaceutical education, 62(3), 1998, pp. 252-257
Citation: R. Kakka et Ma. Kodakimble, CAN INSULIN THERAPY DELAY OR PREVENT INSULIN-DEPENDENT DIABETES-MELLITUS, Pharmacotherapy, 17(1), 1997, pp. 38-44
Citation: Ma. Kodakimble, PREPARING GRADUATES FOR UNCERTAIN FUTURES - LESSONS FROM A STUDENT, American journal of pharmaceutical education, 60(2), 1996, pp. 217-218
Citation: Ma. Kodakimble, MAINTAIN THE BASIC SCIENCES - A PLEA FROM A CLINICAL PROFESSOR, American journal of pharmaceutical education, 59(4), 1995, pp. 425-426
Citation: Ma. Kodakimble, LETS PUT DOC BACK INTO THE PHARMACY - AN OPPORTUNITY FOR AN AACP-NACDS PARTNERSHIP, American journal of pharmaceutical education, 59(3), 1995, pp. 313-314
Citation: Ma. Kodakimble et Fr. Batz, DIABETES CARE AS AN ACTIVE LEARNING-MODEL OF POSTGRADUATE EDUCATION AND TRAINING FOR PHARMACEUTICAL CARE, American journal of pharmaceutical education, 58(4), 1994, pp. 382-385
Authors:
SAUER BL
KODAKIMBLE MA
HERFINDAL ET
INCIARDI JF
Citation: Bl. Sauer et al., EVALUATING CURRICULAR OUTCOMES BY USE OF A LONGITUDINAL ALUMNI SURVEY- INFLUENCE OF GENDER AND RESIDENCY TRAINING, American journal of pharmaceutical education, 58(1), 1994, pp. 16-24
Citation: Mdl. Oconnor et al., MAXIMAL STIMULATION, NOT TACHYPHYLAXIS (TAC), EXPLAINS LOSS OF BETA-CELL RESPONSE TO IV-TOLBUTAMIDE (T) DURING GLYBURIDE (G) THERAPY, Diabetes, 42, 1993, pp. 207-207